Back to search

Article

REBASTINIB, OLVEREMBATINIB, AND NAS-181 INHIBIT <i>MYCOBACTERIUM ABSCESSUS</i> BY DISRUPTING MYCOTHIOL HOMEOSTASIS

2025-08-23

Abstract excerpt

<h4>ABSTRACT</h4> Nontuberculous mycobacteria (NTM), particularly Mycobacterium abscessus , pose a major clinical challenge due to intrinsic drug resistance and limited therapeutic options. In this study, we evaluated three repurposed kinase inhibitors, such as rebastinib, olverembatinib, and NAS-181for their antimycobacterial potential against M. abscessus . All three compounds displayed measurable in vitro ac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
46b74213-8712-5484-9e29-02e4e5d86afa
DOI
10.1101/2025.08.22.671851
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
REBASTINIB, OLVEREMBATINIB, AND NAS-181 INHIBIT <i>MYCOBACTERIUM ABSCESSUS</i> BY DISRUPTING MYCOTHIOL HOMEOSTASISDOI 10.1101/2025.08.22.671851
Select a neighboring publication to make it the new centre.